Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline Embolization Device

Journal of NeuroInterventional Surgery

Volumn 5, Issue SUPPL.3, 2013, Pages

  Delgado Almandoz, Josser E ^a   Crandall, Benjamin M ^a   Scholz, Jill M ^a   Fease, Jennifer L ^a   Anderson, Ruth E ^a   Kadkhodayan, Yasha ^a   Tubman, David E ^a  

^a ABBOTT NORTHWESTERN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DEXAMETHASONE; METHYLPREDNISOLONE; PRASUGREL; PURINERGIC P2Y12 RECEPTOR; TICAGRELOR;

ADULT; ANGIOGRAPHY DEVICE; ANTICOAGULANT THERAPY; APHASIA; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD CLOTTING PARAMETERS; BRAIN ARTERY ANEURYSM; BRAIN HEMORRHAGE; CEREBELLUM INFARCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEMIPARESIS; HEPARINIZATION; HUMAN; HYPERTENSION; IMAGE ANALYSIS; INCIDENCE; LOADING DRUG DOSE; MALE; MICROCATHETER; OPERATIVE BLOOD LOSS; PEROPERATIVE COMPLICATION; PEROPERATIVE THROMBOEMBOLISM; PIPELINE EMBOLIZATION DEVICE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION;

ANEURYSM; FLOW DIVERTER; HEMORRHAGE; PLATELETS; STROKE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CEREBRAL ANGIOGRAPHY; CEREBRAL HEMORRHAGE; COHORT STUDIES; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; INTRACRANIAL ANEURYSM; INTRAOPERATIVE COMPLICATIONS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIOPERATIVE CARE; PREDICTIVE VALUE OF TESTS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y12; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; STENTS; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84879342072     PISSN: 17598478     EISSN: 17598486     Source Type: Journal    
DOI: 10.1136/neurintsurg-2012-010582     Document Type: Article

References (25)

1. Lylyk P, Miranda C, Ceratto R, et al. Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience. Neurosurgery 2009;64:632-42.
2. Szikora I, Berentei Z, Kulcsar Z, et al. Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the pipeline embolization device. AJNR Am J Neuroradiol 2010;31:1139-47.
3. Nelson PK, Lylyk P, Szikora I, et al. The pipeline embolization device for the intracranial treatment of aneurysms trial. AJNR Am J Neuroradiol 2011;32:34-40.
4. Lubicz B, Collignon L, Raphaeli G, et al. Pipeline flow-diverter stent for endovascular treatment of intracranial aneurysms: preliminary experience in 20 patients with 27 aneurysms. World Neurosurg 2011;76:114-19.
5. Fischer S, Vajda Z, Aguilar Perez M, et al. Pipeline embolization device (PED) for neurovascular reconstruction: initial experience in the treatment of 101 intracranial aneurysms and dissections. Neuroradiology 2012;54:369-82.
6. McAuliffe W, Wycoco V, Rice H, et al. Immediate and midterm results following treatment of unruptured intracranial aneurysms with the pipeline embolization device. AJNR Am J Neuroradiol 2012;33:164-70.
7. Deutschmann HA, Wehrschuetz M, Augustin M, et al. Long-term follow-up after treatment of intracranial aneurysms with the Pipeline embolization device: results from a single center. AJNR Am J Neuroradiol 2012;33:481-6.
8. Cruz JP, Chow M, O'Kelly C, et al. Delayed ipsilateral parenchymal hemorrhage following flow diversion for the treatment of anterior circulation aneurysms. AJNR Am J Neuroradiol 2012;33:603-8.
9. Colby GP, Lin LM, Gomez JF, et al. Immediate procedural outcomes in 35 consecutive pipeline embolization cases: a single-center, single-user experience. J Neurointerv Surg 2013;5:237-46.
10. Chitale R, Gonzalez LF, Randazzo C, et al. Single center experience with pipeline stent: feasibility, technique and complications. Neurosurgery 2012;71:679-91.
11. Phillips TJ, Wenderoth JD, Phatouros CC, et al. Safety of the Pipeline embolization device in treatment of posterior circulation aneurysms. AJNR Am J Neuroradiol 2012;33:1225-31.
12. Saatci I, Yavuz K, Ozer C, et al. Treatment of intracranial aneurysms using the Pipeline flow-diverter embolization device. A single-center experience with long-term follow-up results. AJNR Am J Neuroradiol 2012;33:1436-6.
13. O'Kelly CJ, Spears J, Chow M, et al. Canadian experience with the pipeline embolization device for repair of unruptured intracranial aneurysms. AJNR Am J Neuroradiol Published Online First: 2 Aug. 2012. doi: 10.3174/ajnr. A3224
14. Kan P, Siddiqui AH, Veznedaroglu E, et al. Early postmarket results after treatment of intracranial aneurysms with the Pipeline embolization device. A U. S. multicenter experience. Neurosurgery 2012;71:1080-8.
15. Yu SC, Kwok CK, Cheng PW, et al. Intracranial aneurysms: midterm outcome of Pipeline embolization device. A prospective study in 143 patients with 178 aneurysms. Radiology 2012;265:893-901.
16. von Beckerath N, Pogatsa-Murray G, Wieczorek A, et al. Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness. Thromb Haemost 2006;95:910-11.
17. Jakubowski JA, Payne CD, Li YG, et al. The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration. Thromb Haemost 2008;99:409-15.
18. Varenhorst C, James S, Erlinge D, et al. Assessment of P2Y (12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin. Am Heart J 2009;157:562.e1-9.
19. Jeong YH, Bliden KP, Antonino MJ, et al. Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies. Am Heart J 2012;164:35-42.
20. Akbari SH, Reynolds MR, Kadkhodayan Y, et al. Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures. J Neurointerv Surg 2013;5:337-43.
21. Bonello L, Tantry US, Marcucci R, et al. Working group on high on-treatment platelet reactivity. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 2010;56:919-33.
22. Lee DH, Arat A, Morsi H, et al. Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience. AJNR Am J Neuroradiol 2008;29:1389-94.
23. Stetler WR, Chaudhary N, Thompson BG, et al. Prasugrel is effective and safe for neurointerventional procedures. J Neurointerv Surg 2013;5:332-6.
24. Altay T, Kang HI, Woo HH, et al. Thromboembolic events associated with endovascular treatment of cerebral aneurysms. J Neurointerv Surg 2011;3:147-50.
25. Deshmukh V, Hu YC, McDougall CG, et al. Histopathological assessment of delayed ipsilateral parenchymal hemorrhages after the treatment of paraclinoid aneurysms with the Pipeline embolization device (abstract). Neurosurgery 2012;71:E551-2.